Oxcarbazepine Tablet, Film Coated
Product Images NDC 70518-4664

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Oxcarbazepine (NDC 70518-4664). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Remedyrepack Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Remedy_label (Remedy Label)

Label for Oxcarbazepine 600 mg film-coated tablets, oral administration, with a quantity of 30 tablets. The label shows the National Drug Code (NDC) 70518-4664-00, repackaged by RemedyRepack Inc. in Indiana, PA. Includes storage instructions and a QR code on a white background with purple and black text.*

FDA Label Image

Chemical Structure (Oxcarbazepine 01)

Chemical structure of oxcarbazepine, showing its molecular framework with two fused benzene rings, a seven-membered ring containing nitrogen, a ketone group, and an amide substituent.*

FDA Label Image

Figure 1 (Oxcarbazepine 02)

A Kaplan-Meier survival plot showing exit rates over time on trial from Day 2 to Day 11, comparing Oxcarbazepine and Placebo treatment groups. The vertical axis represents exit rate, while the horizontal axis shows time in days. Oxcarbazepine group has a lower exit rate compared to Placebo. The plot includes a log-rank test p-value of 0.0001.*

FDA Label Image

Figure 2 (Oxcarbazepine 03)

A Kaplan-Meier curve chart comparing seizure rates over days from first dose to first seizure between two treatment groups: Oxcarbazepine and Placebo. The x-axis represents days, and the y-axis shows seizure rate. The chart includes a log-rank test p-value of 0.046, indicating a statistical comparison between the groups.*

FDA Label Image

Figure 3 (Oxcarbazepine 04)

A survival curve chart depicting the exit rate over time (days) for two treatment groups labeled HIGH and LOW. The Y-axis represents the exit rate from 0.0 to 1.0, and the X-axis shows time to exit in days, ranging from 0 to 130. The chart includes a log-rank test p-value of 0.0001 indicating a statistical comparison between the groups.*

FDA Label Image

Figure 4 (Oxcarbazepine 05)

A Kaplan-Meier survival curve chart depicting exit rates over time (in days) for two treatment groups labeled HIGH and LOW. The x-axis shows time to exit from 0 to 130 days, and the y-axis shows the exit rate from 0.0 to 1.0. A p-value of 0.0001 from the log-rank test is indicated on the chart, highlighting statistical comparison between the groups.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.